These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10450505)

  • 1. CD30 prevents T-cell responses to non-lymphoid tissues.
    Heath WR; Kurts C; Caminschi I; Carbone FR; Miller JF
    Immunol Rev; 1999 Jun; 169():23-9. PubMed ID: 10450505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells.
    Kurts C; Carbone FR; Krummel MF; Koch KM; Miller JF; Heath WR
    Nature; 1999 Mar; 398(6725):341-4. PubMed ID: 10192335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-presentation of self antigens to CD8+ T cells: the balance between tolerance and autoimmunity.
    Kurts C; Heath WR; Carbone FR; Kosaka H; Miller JF
    Novartis Found Symp; 1998; 215():172-81; discussion 181-90. PubMed ID: 9760579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens.
    Miller JF; Kurts C; Allison J; Kosaka H; Carbone F; Heath WR
    Immunol Rev; 1998 Oct; 165():267-77. PubMed ID: 9850866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells.
    Kurts C; Kosaka H; Carbone FR; Miller JF; Heath WR
    J Exp Med; 1997 Jul; 186(2):239-45. PubMed ID: 9221753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell homeostatic proliferation elicits effective antitumor autoimmunity.
    Dummer W; Niethammer AG; Baccala R; Lawson BR; Wagner N; Reisfeld RA; Theofilopoulos AN
    J Clin Invest; 2002 Jul; 110(2):185-92. PubMed ID: 12122110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1).
    Kurts C; Heath WR; Kosaka H; Miller JF; Carbone FR
    J Exp Med; 1998 Jul; 188(2):415-20. PubMed ID: 9670055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo.
    Fraser JM; Janicki CN; Raveney BJ; Morgan DJ
    Immunology; 2006 Sep; 119(1):126-33. PubMed ID: 16796693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
    Pohl C; Denfeld R; Renner C; Jung W; Bohlen H; Sahin U; Hombach A; van Lier R; Schwonzen M; Diehl V
    Int J Cancer; 1993 Jul; 54(5):820-7. PubMed ID: 7686889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTPN2 restrains CD8⁺ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice.
    Wiede F; Ziegler A; Zehn D; Tiganis T
    J Autoimmun; 2014 Sep; 53():105-14. PubMed ID: 24997008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30-governor of memory T cells?
    Podack ER; Strbo N; Sotosec V; Muta H
    Ann N Y Acad Sci; 2002 Dec; 975():101-13. PubMed ID: 12538158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease.
    Blazar BR; Levy RB; Mak TW; Panoskaltsis-Mortari A; Muta H; Jones M; Roskos M; Serody JS; Yagita H; Podack ER; Taylor PA
    J Immunol; 2004 Sep; 173(5):2933-41. PubMed ID: 15322151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes.
    Sacher T; Knolle P; Nichterlein T; Arnold B; Hämmerling GJ; Limmer A
    Eur J Immunol; 2002 Dec; 32(12):3628-37. PubMed ID: 12516551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells.
    Schuler P; Contassot E; Irla M; Hugues S; Preynat-Seauve O; Beermann F; Donda A; French LE; Huard B
    Cancer Res; 2008 Oct; 68(20):8410-8. PubMed ID: 18922914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells.
    Blanas E; Davey GM; Carbone FR; Heath WR
    J Immunol; 2000 Mar; 164(6):2890-6. PubMed ID: 10706674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity.
    Kurts C; Carbone FR; Barnden M; Blanas E; Allison J; Heath WR; Miller JF
    J Exp Med; 1997 Dec; 186(12):2057-62. PubMed ID: 9396776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction.
    Kurts C; Miller JF; Subramaniam RM; Carbone FR; Heath WR
    J Exp Med; 1998 Jul; 188(2):409-14. PubMed ID: 9670054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens.
    Hamilton-Williams EE; Lang A; Benke D; Davey GM; Wiesmüller KH; Kurts C
    J Immunol; 2005 Feb; 174(3):1159-63. PubMed ID: 15661868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tolerance in CD8+ T cells to a transgenic autoantigen expressed in the liver does not require cross-presentation.
    Morimoto J; Tan X; Teague RM; Ohlén C; Greenberg PD
    J Immunol; 2007 Jun; 178(11):6849-60. PubMed ID: 17513733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.